Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Rev. Cancer3, 422–433 (2003). A comprehensive review on ECM and tumour angiogenesis. ArticleCAS Google Scholar
Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med.285, 1182–1186 (1971). The first publication to indicate that angiogenesis is a target for controlling cancer. ArticleCASPubMed Google Scholar
O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell88, 277–285 (1997). ArticleCASPubMed Google Scholar
Ishii, G. et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun.309, 232–240 (2003). ArticleCASPubMed Google Scholar
Kim, K. J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature362, 841–844 (1993). ArticleCASPubMed Google Scholar
de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell7, 411–423 (2005). ArticleCASPubMed Google Scholar
Tlsty, T. D. & Hein, P. W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev.11, 54–59 (2001). An interesting review of tumour stromal cells and their role in oncogenic manipulation. ArticleCASPubMed Google Scholar
Elenbaas, B. & Weinberg, R. A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res.264, 169–184 (2001). ArticleCASPubMed Google Scholar
Mueller, M. M. & Fusenig, N. E. Friends or foes — bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer4, 839–849 (2004). An in-depth review about tumour stroma. ArticleCAS Google Scholar
Virchow, R. Die Cellularpathologie in Ihrer Begruendung auf Physiologische und Pathologische Gewebelehre (Hirschwald, A., Berlin, Germany, 1858). Google Scholar
Duvall, M. Atlas d'Embryologie (Masson, Paris, 1879). Google Scholar
Tarin, D. & Croft, C. B. Ultrastructural features of wound healing in mouse skin. J. Anat.105, 189–190 (1969). CASPubMed Google Scholar
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Rev. Mol. Cell Biol.3, 349–363 (2002). ArticleCAS Google Scholar
Rodemann, H. P. & Muller, G. A. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am. J. Kidney Dis.17, 684–686 (1991). ArticleCASPubMed Google Scholar
Chang, H. Y. et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA99, 12877–12882 (2002). This study compares primary fibroblasts that were isolated from various sites and sheds new light on the vast diversity of fibroblasts. ArticleCASPubMedPubMed Central Google Scholar
Simian, M. et al. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development128, 3117–3131 (2001). ArticleCASPubMed Google Scholar
Castor, C. W., Wilson, S. M., Heiss, P. R. & Seidman, J. C. Activation of lung connective tissue cells in vitro. Am. Rev. Respir. Dis.120, 101–106 (1979). CASPubMed Google Scholar
Muller, G. A. & Rodemann, H. P. Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am. J. Kidney Dis.17, 680–683. (1991). ArticleCASPubMed Google Scholar
Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell100, 57–70 (2000). A comprehensive review on cancer. ArticleCASPubMed Google Scholar
Ronnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev.76, 69–125 (1996). ArticleCASPubMed Google Scholar
Dvorak, H. F., Form, D. M., Manseau, E. J. & Smith, B. D. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J. Natl Cancer Inst.73, 1195–1205 (1984). CASPubMed Google Scholar
Dolberg, D. S., Hollingsworth, R., Hertle, M. & Bissell, M. J. Wounding and its role in RSV-mediated tumor formation. Science230, 676–678 (1985). ArticleCASPubMed Google Scholar
Sieweke, M. H., Thompson, N. L., Sporn, M. B. & Bissell, M. J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science248, 1656–1660 (1990). ArticleCASPubMed Google Scholar
Brown, L. F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res.5, 1041–1056 (1999). CASPubMed Google Scholar
Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell94, 715–725 (1998). ArticleCASPubMed Google Scholar
Senger, D. R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science219, 983–985 (1983). ArticleCASPubMed Google Scholar
Dvorak, H. F. et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med.174, 1275–1278 (1991). ArticleCASPubMed Google Scholar
Feng, D. et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J. Histochem. Cytochem.48, 545–556 (2000). ArticleCASPubMed Google Scholar
Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science246, 1306–1309 (1989). ArticleCASPubMed Google Scholar
Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med.315, 1650–1659 (1986). ArticleCASPubMed Google Scholar
Shekhar, M. P., Pauley, R. & Heppner, G. Host microenvironment in breast cancer development: extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res.5, 130–135 (2003). ArticleCASPubMedPubMed Central Google Scholar
van Kempen, L. C., Ruiter, D. J., van Muijen, G. N. & Coussens, L. M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol.82, 539–548 (2003). ArticlePubMed Google Scholar
Brown, L. F., Dvorak, A. M. & Dvorak, H. F. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am. Rev. Respir. Dis.140, 1104–1107 (1989). ArticleCASPubMed Google Scholar
Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature339, 58–61 (1989). ArticleCASPubMed Google Scholar
Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A. & Sakakura, T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell47, 131–139 (1986). ArticleCASPubMed Google Scholar
Mackie, E. J. et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl Acad. Sci. USA84, 4621–4625 (1987). ArticleCASPubMedPubMed Central Google Scholar
Ishihara, A., Yoshida, T., Tamaki, H. & Sakakura, T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin. Cancer Res.1, 1035–1041 (1995). CASPubMed Google Scholar
Brunner, A. et al. Prognostic significance of tenascin-C-expression in superficial and invasive bladder cancer. J. Clin. Pathol.57, 927–931 (2004). ArticleCASPubMedPubMed Central Google Scholar
De Wever, O. & Mareel, M. Role of myofibroblasts at the invasion front. Biol. Chem.383, 55–67 (2002). ArticleCASPubMed Google Scholar
Bertrand, P. et al. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J. Cancer52, 1–6 (1992). ArticleCASPubMed Google Scholar
Barsky, S. H. & Gopalakrishna, R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res.47, 1663–1667 (1987). CASPubMed Google Scholar
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J. & Jain, R. K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res.60, 2497–2503 (2000). CASPubMed Google Scholar
Brown, E. B., Boucher, Y., Nasser, S. & Jain, R. K. Measurement of macromolecular diffusion coefficients in human tumors. Microvasc. Res.67, 231–236 (2004). ArticleCASPubMed Google Scholar
Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell69, 11–25 (1992). ArticleCASPubMed Google Scholar
Ryan, G. B. et al. Myofibroblasts in an avascular fibrous tissue. Lab. Invest.29, 197–206 (1973). CASPubMed Google Scholar
Tsukada, T., McNutt, M. A., Ross, R. & Gown, A. M. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am. J. Pathol.127, 389–402 (1987). CASPubMedPubMed Central Google Scholar
Schor, S. L., Schor, A. M., Grey, A. M. & Rushton, G. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J. Cell Sci.90, 391–399 (1988). ArticleCASPubMed Google Scholar
Durning, P., Schor, S. L. & Sellwood, R. A. Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet2, 890–892 (1984). ArticleCASPubMed Google Scholar
Barsky, S. H., Green, W. R., Grotendorst, G. R. & Liotta, L. A. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am. J. Pathol.115, 329–333 (1984). CASPubMedPubMed Central Google Scholar
Sappino, A. P., Skalli, O., Jackson, B., Schurch, W. & Gabbiani, G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer41, 707–712 (1988). ArticleCASPubMed Google Scholar
Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol.200, 500–503 (2003). ArticleCASPubMed Google Scholar
Ronnov-Jessen, L. & Petersen, O. W. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest.68, 696–707 (1993). CASPubMed Google Scholar
Lohr, M. et al. Transforming growth factor-β1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res.61, 550–555 (2001). CASPubMed Google Scholar
Aoyagi, Y. et al. Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer91, 1316–1326 (2004). ArticleCASPubMedPubMed Central Google Scholar
Bronzert, D. A. et al. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc. Natl Acad. Sci. USA84, 5763–5767 (1987). ArticleCASPubMedPubMed Central Google Scholar
Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M. & Westermark, B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl Acad. Sci. USA90, 393–397 (1993). ArticleCASPubMedPubMed Central Google Scholar
Shao, Z. M., Nguyen, M. & Barsky, S. H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene19, 4337–4345 (2000). ArticleCASPubMed Google Scholar
Armelin, H. A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl Acad. Sci. USA70, 2702–2706 (1973). ArticleCASPubMedPubMed Central Google Scholar
Folkman, J. et al. A heparin-binding angiogenic protein — basic fibroblast growth factor — is stored within basement membrane. Am. J. Pathol.130, 393–400 (1988). CASPubMedPubMed Central Google Scholar
Strutz, F. et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int.57, 1521–1538. (2000). ArticleCASPubMed Google Scholar
Thiery, J. P. Epithelial–mesenchymal transitions in tumor progression. Nature Rev. Cancer2, 442–454 (2002). A good review on the role of EMT in cancer. ArticleCAS Google Scholar
Kalluri, R. & Neilson, E. G. Epithelial–mesenchymal transition and its implications for fibrosis. J. Clin. Invest.112, 1776–1784 (2003). ArticleCASPubMedPubMed Central Google Scholar
Fukino, K. et al. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res.64, 7231–7236 (2004). ArticleCASPubMed Google Scholar
Tuhkanen, H. et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int. J. Cancer109, 247–252 (2004). ArticleCASPubMed Google Scholar
Ellsworth, D. L. et al. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Breast Cancer Res. Treat.88, 131–139 (2004). ArticleCASPubMed Google Scholar
Kurose, K. et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet.32, 355–357 (2002). ArticleCASPubMed Google Scholar
Petersen, O. W. et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol.162, 391–402 (2003). An interesting study indicating that cancer cells can contribute to the accumulation of stromal fibroblasts by undergoing a complete EMT. ArticleCASPubMedPubMed Central Google Scholar
Zeisberg, M. & Kalluri, R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med.82, 175–181 (2004). ArticlePubMed Google Scholar
Zeisberg, M. et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Med.9, 964–968 (2003). The first study to indicate that targeting EMT can reduce the numbers of tissue fibroblasts and reverse fibrosis. ArticleCASPubMed Google Scholar
Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest.110, 341–350. (2002). Provides evidence that FSP1 protein is a fibroblast-specific protein, and provides further evidence relating to the role of EMT in organ fibrosis. ArticleCASPubMedPubMed Central Google Scholar
Kopelovich, L. Genetic predisposition to cancer in man: in vitro studies. Int. Rev. Cytol.77, 63–88 (1982). ArticleCASPubMed Google Scholar
Schor, S. L. et al. Occurrence of a fetal fibroblast phenotype in familial breast cancer. Int. J. Cancer37, 831–836 (1986). ArticleCASPubMed Google Scholar
Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA101, 4966–4971 (2004). Demonstrates that fibroblasts aid mammary epithelia in forming functional breast tissue, and carcinogenesis. ArticleCASPubMedPubMed Central Google Scholar
Bhowmick, N. A. et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science303, 848–851 (2004). Indicates that deletion of TGFβ type II receptor in FSP1-positive cells leads to the emergence of epithelial tumours. ArticleCASPubMed Google Scholar
Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell121, 335–348 (2005). Indicates a prominent role for fibroblasts in tumour angiogenesis facilitated by SDF1. ArticleCASPubMed Google Scholar
Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res.59, 5002–5011 (1999). A study that used co-culture methods to elucidate the role of CAFs in cancer progression. CASPubMed Google Scholar
Dimanche-Boitrel, M. T. et al. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int. J. Cancer56, 512–521 (1994). ArticleCASPubMed Google Scholar
Boire, A. et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell120, 303–313 (2005). ArticleCASPubMed Google Scholar
Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol.9, 541–573 (1993). ArticleCASPubMed Google Scholar
Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol.139, 1861–1872 (1997). ArticleCASPubMedPubMed Central Google Scholar
Olaso, E. et al. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology26, 634–642 (1997). ArticleCASPubMed Google Scholar
Olaso, E. et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology37, 674–685 (2003). ArticleCASPubMed Google Scholar
Cornil, I. et al. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl Acad. Sci. USA88, 6028–6032 (1991). ArticleCASPubMedPubMed Central Google Scholar
Grum-Schwensen, B. et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4mts1 gene. Cancer Res.65, 3772–3780 (2005). ArticleCASPubMed Google Scholar
Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Rev. Cancer3, 807–821 (2003). ArticleCAS Google Scholar
Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet.29, 117–129 (2001). ArticleCASPubMed Google Scholar
Cheng, N. et al. Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks. Oncogene24, 5053–5068 (2005). ArticleCASPubMedPubMed Central Google Scholar
Silzle, T., Randolph, G. J., Kreutz, M. & Kunz-Schughart, L. A. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer108, 173–180 (2004). ArticleCASPubMed Google Scholar
Rettig, W. J. et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res.53, 3327–3335 (1993). CASPubMed Google Scholar
Wang, X. M., Yu, D. M., McCaughan, G. W. & Gorrell, M. D. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology42, 935–945 (2005). ArticleCASPubMed Google Scholar
Scott, A. M. et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res.9, 1639–1647 (2003). CASPubMed Google Scholar
Zeisberg, M. et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal Physiol.285, F1060–F1067 (2003). ArticleCASPubMed Google Scholar
Zeisberg, M., Strutz, F. & Muller, G. A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol.13 (Suppl. 3), S111–S120 (2000). PubMed Google Scholar
Nakamura, T. et al. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am. J. Physiol. Heart Circ. Physiol.288, H2131–H2139 (2005). ArticleCASPubMed Google Scholar
Kim, W. H., Matsumoto, K., Bessho, K. & Nakamura, T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am. J. Pathol.166, 1017–1028 (2005). ArticleCASPubMedPubMed Central Google Scholar
Dai, C. et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J. Am. Soc. Nephrol.15, 2637–2647 (2004). ArticleCASPubMed Google Scholar
Isaka, Y. et al. Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Ther.12, 815–820 (2005). ArticleCASPubMed Google Scholar
Yang, J., Dai, C. & Liu, Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J. Am. Soc. Nephrol.13, 2464–2477 (2002). ArticleCASPubMed Google Scholar
McDonald, G. A. et al. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am. J. Physiol. Renal Physiol.285, F59–F67 (2003). ArticleCASPubMed Google Scholar
Heeg, M. H. et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int.68, 96–109 (2005). ArticleCASPubMed Google Scholar
Samuel, C. S. et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology145, 4125–4133 (2004). ArticleCASPubMed Google Scholar
Seibold, J. R. et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med.132, 871–879 (2000). ArticleCASPubMed Google Scholar
Binder, C. et al. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res. Treat.87, 157–166 (2004). ArticleCASPubMed Google Scholar
Binder, C., Hagemann, T., Husen, B., Schulz, M. & Einspanier, A. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol. Hum. Reprod.8, 789–796 (2002). ArticleCASPubMed Google Scholar
Lazarides, E. & Balzer, D. R. Jr. Specificity of desmin to avian and mammalian muscle cells. Cell14, 429–438 (1978). ArticleCASPubMed Google Scholar
Franke, W. W., Schmid, E., Osborn, M. & Weber, K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc. Natl Acad. Sci. USA75, 5034–5038 (1978). ArticleCASPubMedPubMed Central Google Scholar
Franke, W. W., Schmid, E., Osborn, M. & Weber, K. Intermediate-sized filaments of human endothelial cells. J. Cell Biol.81, 570–580 (1979). ArticleCASPubMed Google Scholar
Mork, C., van Deurs, B. & Petersen, O. W. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation43, 146–156 (1990). ArticleCASPubMed Google Scholar
Schmid, E. et al. Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp. Cell Res.137, 329–340 (1982). ArticleCASPubMed Google Scholar
Strutz, F. et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol.130, 393–405 (1995). ArticleCASPubMed Google Scholar
Vogel, W., Gish, G. D., Alves, F. & Pawson, T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell1, 13–23 (1997). ArticleCASPubMed Google Scholar
Goldsmith, E. C. et al. Organization of fibroblasts in the heart. Dev. Dyn.230, 787–794 (2004). ArticleCASPubMed Google Scholar
Ramirez-Montagut, T. et al. FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene23, 5435–5446 (2004). ArticleCASPubMed Google Scholar
Gardner, H., Kreidberg, J., Koteliansky, V. & Jaenisch, R. Deletion of integrin α1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev. Biol.175, 301–313 (1996). ArticleCASPubMed Google Scholar
Sudhakar, A. et al. Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin. J. Clin. Invest.115, 2801–2810 (2005). ArticleCASPubMedPubMed Central Google Scholar
Mussini, E., Hutton, J. J. Jr & Udenfriend, S. Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science157, 927–929 (1967). ArticleCASPubMed Google Scholar
Florin, L. et al. Cre recombinase-mediated gene targeting of mesenchymal cells. Genesis38, 139–144 (2004). ArticleCASPubMed Google Scholar
Hogan, B. L. & Yingling, J. M. Epithelial–mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev.8, 481–486 (1998). ArticleCASPubMed Google Scholar
Clayton, A. et al. Cellular activation through the ligation of intercellular adhesion molecule-1. J. Cell Sci.111, 443–453 (1998). ArticleCASPubMed Google Scholar
Strieter, R. M. et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun.162, 694–700 (1989). ArticleCASPubMed Google Scholar
Rollins, B. J., Stier, P., Ernst, T. & Wong, G. G. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol.9, 4687–4695 (1989). CASPubMedPubMed Central Google Scholar
Duda, D. G. et al. Differential transplantability of tumor-associated stromal cells. Cancer Res.64, 5920–5924 (2004). ArticleCASPubMed Google Scholar
Grupp, C. et al. A novel model to study renal myofibroblast formation in vitro. Kidney Int.59, 543–553 (2001). ArticleCASPubMed Google Scholar